1. Introduction
===============

Chicken growth traits play a crucial role in poultry production, which is affected by multiple factors, including genetic, nutritional, and environmental features \[[@B1-ijms-16-16242]\]. In the past two decades, many growth candidate genes and quantitative trait loci (QTLs) for chicken growth have been identified \[[@B2-ijms-16-16242],[@B3-ijms-16-16242],[@B4-ijms-16-16242],[@B5-ijms-16-16242],[@B6-ijms-16-16242],[@B7-ijms-16-16242]\]. With the development of next generation sequencing, a number of genome-wide association studies (GWAS) and transcriptome sequencing analyses were performed; more candidate genes and significant SNPs were found to influence chicken growth traits \[[@B8-ijms-16-16242],[@B9-ijms-16-16242],[@B10-ijms-16-16242],[@B11-ijms-16-16242],[@B12-ijms-16-16242]\]. However, there are few studies about other genetic factors affecting chicken growth, such as microRNA regulation and epigenetic inheritance, and the genetic mechanisms of chicken growth are far from clear.

MicroRNAs, a class of non-coding small RNA with 20--23 nucleotides in length, can regulate gene expression by targeting specific sites in the 3′-untranslated region (3′-UTR) of mRNAs \[[@B13-ijms-16-16242]\]. Increasing studies indicate that miRNAs widely control biological and metabolic processes by regulating post-transcriptional gene expression \[[@B14-ijms-16-16242],[@B15-ijms-16-16242],[@B16-ijms-16-16242]\]. Furthermore, variations of microRNA may lead to abnormal function, and change the phenotypic character \[[@B17-ijms-16-16242],[@B18-ijms-16-16242]\]. Until now, chicken has the highest numbers of identified miRNAs in domestic animals; 1058 chicken miRNAs have been identified based on the database of miRase 21.0 \[[@B19-ijms-16-16242]\]. Several studies have found miRNAs associated with embryo development \[[@B20-ijms-16-16242],[@B21-ijms-16-16242]\], cell proliferation \[[@B22-ijms-16-16242]\], immunity function \[[@B23-ijms-16-16242],[@B24-ijms-16-16242],[@B25-ijms-16-16242]\], and skeletal muscle development in chicken \[[@B26-ijms-16-16242]\]. Therefore, miRNAs may play an important role in affecting chicken growth traits.

The aim of the present study was to identify miRNAs associated with growth traits in chicken. Breast muscle tissues of two-tail samples from WRR and XH, which exhibit different growth performance at seven weeks of age, were used for high throughput small RNA deep sequencing to detect the differentially expressed miRNAs.

2. Results
==========

2.1. Overview of Small RNA Deep Sequencing Data
-----------------------------------------------

In this study, three pooled breast muscle tissues for each group of WRRh (the group of Recessive White Rock with high body weight), WRRl (the group of Recessive White Rock with low body weight), XHh (the group of Xinhua Chickens with high body weight) and XHl (the group of Xinhua Chickens with low body weight) were sequenced simultaneously by Illumina Solexa sequencing. All sequencing data were submitted to the NCBI GEO database with the accession number GSE62971 \[[@B27-ijms-16-16242]\]. A range of 22,080,436 to 16,410,221 raw reads for the four groups was obtained. Firstly, low-quality reads and meaningless reads were filtered out. The quality data for RNA samples are shown in [Figure S1](#app1-ijms-16-16242){ref-type="app"}. A total of 20,424,161, 18,160,137, 14,806,039 and 17,295,270 clean reads was obtained for WRRh, WRRl, XHh and XHl, respectively ([Table 1](#ijms-16-16242-t001){ref-type="table"}). The size distribution of clean reads was assessed for all four groups. Small RNA sequence length was mainly concentrated at 21--24 nt, and the length of 22 nt was the maximum size ([Figure 1](#ijms-16-16242-f001){ref-type="fig"}).
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###### 

Summary of data generated from small RNA deep sequencing.

  Sample     Total Reads   Clean Reads   Unique Reads   Mapped Reads ^a^   Percentage ^b^
  ---------- ------------- ------------- -------------- ------------------ ----------------
  **WRRh**   22,080,436    20,424,161    577,820        433,846            75.08%
  **WRRl**   19,917,025    18,160,137    513,726        392,323            76.37%
  **XHh**    16,410,221    14,806,039    494,539        366,898            74.19%
  **XHl**    19,473,651    17,295,270    625,063        482,989            77.27%

^a^ The unique reads mapped in chicken genome; ^b^ The percentage of mapped reads in unique reads.

![Length distribution and abundance of small RNAs sequences in chicken breast tissue. Clean reads of 18--32 nt for all four groups were assessed for size distribution; and the most abundant size class was 22 nt; followed by 23 and 24 nt.](ijms-16-16242-g001){#ijms-16-16242-f001}

Then, the clean reads were assembled by groups, giving rise to 577,820, 513,726, 494,539, and 625,063 unique sequences for WRRh, WRRl, XHh, and XHl, respectively ([Table 1](#ijms-16-16242-t001){ref-type="table"}). The unique small RNA reads were mapped to the chromosome by blasting with the chicken genome. Results showed that over 70% of the reads could be perfectly mapped to the chicken genome. Moreover, they were mainly located at chromosome 1 (29.25%), 2 (7.96%), 3 (6.71%), 4 (4.97%), 5 (4.71%) and 7 (9.59%) ([Figure 2](#ijms-16-16242-f002){ref-type="fig"}). Finally, the type and number of sRNA were searched using Rfam databases (rRNA, tRNA, sn/snoRNA, miRNAs, other noncoding RNA). The unique sequences were categorized into seven groups; 71.0% of them were defined as miRNAs, 14% were unmatched, and 15% were other known categories of identified small RNA including rRNA, tRNA, snRNA, snoRNA, *etc.* ([Figure 3](#ijms-16-16242-f003){ref-type="fig"}).

![Distribution percentages of unique small RNAs sequences on chicken chromosome. The unique small RNA reads were mapped to chromosome by BLASTing with the chicken genome; and then the percentages of mapped reads of each chromosome in total mapped reads were then calculated. Chr MT: mitochondrial genome.](ijms-16-16242-g002){#ijms-16-16242-f002}

![Frequency of unique small RNA distribution among the different categories. The unique sequences were subjected to searches for the types and numbers of sRNA using the Rfam databases (rRNA; tRNA; sn/snoRNA; miRNAs; other noncoding RNA).](ijms-16-16242-g003){#ijms-16-16242-f003}

2.2. Characterization of Known miRNAs and Predicted Novel miRNAs
----------------------------------------------------------------

Known conserved miRNAs were identified from the breast muscle of four groups using miRBase 21.0 (<http://www.mirbase.org/>), and novel miRNAs were also predicted from unannotated sRNA by miRDeep2 \[[@B28-ijms-16-16242]\]. In this study, a total of 921 miRNAs (733 known mature miRNAs and 188 novel miRNAs) were detected. There were 891 and 797 miRNAs in WRR and the XH chicken each, of which 477 known mature miRNAs were expressed in all four groups ([Table S1 in supplementary materials](#app1-ijms-16-16242){ref-type="app"}).

The abundance of the miRNAs could reflect differences in the roles of these miRNAs in the regulation of growth. The top 20 abundant known miRNAs in our libraries are listed in [Table 2](#ijms-16-16242-t002){ref-type="table"}. The most abundant miRNAs is the gga-miR-133 family, which includes gga-miR-133a, gga-miR-133b and gga-miR-133c. The let-7 family was also expressed abundantly in the breast muscle libraries, five of them (gga-let-7a, gga-let-7c, gga-let-7f, gga-let-7j and gga-let-7k) are in the list of the top 20 abundant miRNAs. We found that putative novel miRNAs were less abundant than known miRNAs. There were 12 putative novel miRNAs and 131 known miRNAs in the libraries which have read counts greater than 1000 ([Table S2 in supplementary materials](#app1-ijms-16-16242){ref-type="app"}). The predicted secondary structures of the two most abundant novel miRNAs are shown in [Figure S2](#app1-ijms-16-16242){ref-type="app"}. Comparing the chicken miRNAs sequences, heterogeneity at the 5′ and/or 3′ ends of miRNAs was observed ([Figure S3](#app1-ijms-16-16242){ref-type="app"}). These variations of miRNAs from their miRBase reference sequences are referred to as isomiRs \[[@B29-ijms-16-16242]\]. We found that many miRNAs have various isoforms in chicken breast muscle libraries, and some miRNAs have more than one highly abundant isoform (e.g., gga-let-7c, gga-miR-205a and gga-miR-223). In addition to a few miRNAs (e.g., gga-let-7c), the most abundant isoforms are identical to the reference in miRBase. The most highly expressed miRNAs appear to have a greater number of different isoforms, e.g., 26 isoforms of gga-let-7c were identified.
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###### 

The top 20 abundant known miRNAs in chicken breast muscles.

  miRNAs                Normalized Reads   Total Reads                           
  --------------------- ------------------ ------------- ----------- ----------- ------------
  **gga-miR-133a**      3,558,683          3,069,071     1,997,286   2,607,787   11,232,827
  **gga-miR-133c**      3,350,936          2,885,440     1,878,925   2,449,209   10,564,510
  **gga-miR-133b**      3,326,848          2,864,578     1,864,721   2,431,274   10,487,421
  **gga-let-7a**        1,699,621          1,513,865     857,210     1,133,532   5,204,228
  **gga-miR-22-3p**     1,333,233          1,145,421     712,464     988,186     4,179,304
  **gga-miR-30a-5p**    1,213,468          1,148,128     790,893     930,507     4,082,996
  **gga-miR-26a**       1,212,635          1,054,689     691,456     1,006,522   3,965,302
  **gga-miR-30d**       851,887            813,262       583,932     667,002     2,916,083
  **gga-miR-181a-6p**   918,452            836,452       485,661     650,836     2,891,401
  **gga-miR-10a-5p**    943,686            782,180       420,809     663,401     2,810,076
  **gga-miR-10b**       911,725            757,564       398,852     633,567     2,701,708
  **gga-miR-30e**       799,679            730,832       501,718     596,218     2,628,447
  **gga-let-7j**        848,972            756,205       428,182     566,165     2,599,524
  **gga-let-7f**        398,292            363,598       206,995     274,333     1,243,218
  **gga-miR-148a**      288,585            300,432       144,015     180,973     914,005
  **gga-miR-146c-5p**   224,147            207,782       171,443     132,712     736,084
  **gga-let-7k**        211,853            206,518       118,297     155,412     692,080
  **gga-let-7c**        242,661            189,820       111,118     139,257     682,856
  **gga-miR-199-3p**    168,417            152,158       75,346      121,460     517,381
  **gga-miR-126-5p**    139,914            109,805       89,607      86,681      426,007

2.3. Identification of Differentially Expressed miRNAs
------------------------------------------------------

Differentially expressed miRNAs were identified by DEGseq analysis (fold change \> 1.5 or \< 0.66; *p*-value \< 0.05; *q*-value \< 0.01), as a result, 200, 279, 257 and 297 miRNAs were detected in four comparisons of WRRh *vs.* WRRl, WRRh *vs.* XHh, WRRl *vs.* XHl and XHh *vs.* XHl, respectively. Multiple comparisons revealed 80 miRNAs within breeds (WRRh *vs.* WRRl and XHh *vs.* XHl), and 110 miRNAs between breeds (WRRh *vs.* XHh and WRRl *vs.* XHl). The details of differentially expressed miRNAs are shown in [Table S3 in supplementary materials](#app1-ijms-16-16242){ref-type="app"}. Among them, moreover, 26 miRNAs (including 10 known miRNAs of miR-122, miR-1329-3p, miR-1587, miR-1736-3p, miR-1769-3p, miR-1769-5p, miR-1773-5p, miR-205a, miR-31 and miR-375) were found in all four comparisons ([Table 3](#ijms-16-16242-t003){ref-type="table"}). Furthermore, we focused on the miRNAs that were both abundant (read counts \> 1000) and highly differentially expressed (fold change \> 2 or \< 0.5; *p*-value \< 0.05; *q*-value \< 0.01) in our comparisons, and found that 22 miRNAs met the standards ([Table 4](#ijms-16-16242-t004){ref-type="table"}).
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###### 

Statistics of significant differently expressed miRNAs.

  Sample 1 *vs.* Sample 2   Up ^a^     Down ^b^   Total       Shared     
  ------------------------- ---------- ---------- ----------- ---------- ---------
  **WRRh *vs.* WRRl**       116 (47)   84 (24)    200 (71)    80 (22)    26 (16)
  **XHh *vs.* XHl**         129 (44)   150 (40)   279 (84)               
  **WRRh *vs.* XHh**        130 (31)   127 (47)   257 (78)    110 (39)   
  **WRR *vs.* XHl**         137 (41)   160 (60)   297 (101)              

^a^ The numbers of miRNAs expressed in sample 1 more than sample 2; ^b^ The numbers of miRNAs expressed in sample 1 were lower than sample 2. The value in brackets is the number of novel miRNAs. WRRh *vs.* WRRl indicated the comparison between the two-tail samples of Recessive White Rock; XHh *vs.* XHl indicated the comparison between the two-tail samples of Xinhua Chickens; WRRh *vs* XHh indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with high body weight; WRRl *vs.* XHl indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with low body weight.
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###### 

Differently expressed miRNAs and their candidate target genes.

  miRNAs                Normalized Reads   Fold Change      Target Gene                         
  --------------------- ------------------ ---------------- ----------------------------------- ----------------------------
  **gga-miR-1329-5p**   WRRh 459           WRRl 1582        0.29                                *EDNRB*; *WWP2*
  WRRl 1582             XHl 174            9.07                                                 
  **gga-miR-1416-5p**   XHh 5680           XHl 2721         2.09                                *CTGF*; *CXCL12*
  WRRl 8061             XHl 2721           2.96                                                 
  **gga-miR-142-5p**    WRRh 108,463       XHh 54,059       2.01                                *FOXO3*; *ITGA8*
  WRRl 173,442          XHl 71,860         2.41                                                 
  **gga-miR-146b-3p**   WRRl 5800          XHl 2404         2.41                                *TNNC1*; *AKT1*; *GHR*
  **gga-miR-146b-5p**   WRRl 191,004       XHl 71,169       2.68                                --
  **gga-miR-147**       WRRh 882           WRRl 2824        0.31                                --
  WRRl 2824             XHl 928            3.04                                                 
  **gga-miR-155**       WRRh 5205          WRRl 14,058      0.37                                *ACTA1*; *AKT1*; *EDNRA*
  WRRh 5205             XHh 1759           2.96                                                 
  WRRl 14,058           XHl 2018           6.97                                                 
  **gga-miR-1744-3p**   WRRh 2359          WRRl 740         3.19                                *TMOD1*; *EDN3*
  **gga-miR-1769-3p**   WRRh 377           WRRl 1120        0.34                                *DMD*; *BMP10*
  WRRl 1120             XHl 498            2.25                                                 
  **gga-miR-184**       WRRh 382           XHh 1735         0.22                                *COL11A1*
  **gga-miR-194**       WRRh 946           WRRl 4669        0.20                                *MYBPC3*; *GCG*
  WRRh 946              XHh 1981           0.48                                                 
  WRRl 4669             XHl 1470           3.18                                                 
  **gga-miR-204**       XHh 2762           XHl 5848         0.47                                *MYO6*; *PDGFRA*; *SOCS3*
  **gga-miR-205a**      WRRh 4900          WRRl 2281        2.15                                *CISH*; *IFNG*
  WRRh 4900             XHh 2137           2.29                                                 
  WRRl 2281             XHl 940            2.43                                                 
  **gga-miR-21**        WRRh 489,673       WRRl 1,060,669   0.46                                *CISH*
  WRRl 1,060,669        XHl 360,267        2.94                                                 
  **gga-miR-222b-3p**   WRRh 2477          WRRl 6641        0.37                                *ITGB1*
  WRRh 2477             XHh 658            3.77                                                 
  WRRl 6641             XHl 791            8.40                                                 
  **gga-miR-223**       WRRl 10,225        XHl 4004         2.55                                *MYH10*; *ADAM17*; *FOXO3*
  **gga-miR-34b**       XHh 41             XHl 1750         0.02                                *MYH10*; *BMP10*
  WRRl 218              XHl 1750           0.12             *STRAP*; *THY1*                     
  **gga-miR-34c**       XHh 41             XHl 1750         0.02                                *MYH7B*; *APP*
  WRRl 218              XHl 1750           0.12             *THY1*; *COL11A1*; *SOCS3*; *GCG*   
  **gga-miR-383**       WRRh 373           1603             0.23                                *MYH7*; *APP*; *ITGA8*
  **gga-miR-499**       WRRl 1754          XHl 6084         0.29                                *ADAM17*; *FLNB*
  **gga-miR-9-3p**      XHh 82             XHl 1177         0.07                                *ACTG1*
  WRRl 81               XHl 1177           0.07                                                 
  **gga-miR-9-5p**      XHh 1036           XHl 3095         0.33                                *TGFB2*

The miRNAs were both abundant (read counts \> 1000) and highly differentially expressed (fold change \> 2 or \< 0.5; *p*-value \< 0.05; *q*-value \< 0.01) in our comparisons; the target genes were involved in growth related gene interaction networks.

To verify the RNA-Seq data, the differential expression of four miRNAs including miR-223, miR-16, miR-205a and miR-222b-5p were validated by qRT-PCR among all four comparisons ([Figure 4](#ijms-16-16242-f004){ref-type="fig"}). In general, except for miR-222b-5p in XHh *vs.* XHl contrast, the expression patterns of these four miRNAs were consistent with the RNA-Seq results, indicating that the deep sequencing results were reliable and appropriate for further analysis.

![qRT-PCR validation of four differentially expressed miRNAs in all four comparisons. (**A**) WRRh *vs*. XHh; (**B**) WRRh *vs.* WRRl; (**C**) WRRl *vs.* XHl; (**D**) XHh *vs.* XHl. qRT-PCR reactions were run in triplicates and presented as means ± S.E.M. The Student's *t*-test was used to compare expression levels among different groups. \* *p* \< 0.05; \*\* *p* \< 0.01. WRRh *vs.* WRRl indicated the comparison between the two-tail samples of Recessive White Rock; XHh *vs.* XHl indicated the comparison between the two-tail samples of Xinhua Chickens; WRRh *vs.* XHh indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with high body weight; WRRl *vs.* XHl indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with low body weight.](ijms-16-16242-g004){#ijms-16-16242-f004}

2.4. Target Gene Prediction, Function Annotation and Network Analysis
---------------------------------------------------------------------

Through miRanda and RANhybrid, a total of 22,194 consensus potential miRNAs targets were obtained for all differentially expressed miRNAs. For all potential targets, GO annotation and KEGG pathway analysis were performed to identify functional modules. The GO results showed that 16,428 genes were involved in the categories and 502 biological process categories were significantly enriched (*p* \< 0.05). The top 29 GO terms with enriched genes over 1000 were listed in [Table S4 in supplementary materials](#app1-ijms-16-16242){ref-type="app"}. Pathway analysis of all targets revealed that 65 KEGG pathways were significantly enriched (*p* \< 0.05), including 13 in WRRh *vs.* WRRl, 12 in XHh *vs.* XHl, 8 in WRRh *vs.* XHh, and 15 in WRRl *vs.* XHl ([Table S5 in supplementary materials](#app1-ijms-16-16242){ref-type="app"}). Lysosome and metabolic pathways were enriched in all four comparisons.

For the 22 highly differentially expressed miRNAs ([Table 4](#ijms-16-16242-t004){ref-type="table"}), 3151 potential targets were obtained by both miRanda \[[@B30-ijms-16-16242]\] and RNAhybrid \[[@B31-ijms-16-16242]\]. The further GO analysis for these targets showed that 192 biological process categories were significantly enriched (*p* \< 0.05). The important growth-related GO terms are listed in [Table 5](#ijms-16-16242-t005){ref-type="table"}, and are involved in regulation of growth, cell growth, muscle cell differentiation and development, and the transforming growth factor beta receptor signaling pathway. These GO terms contained 87 target genes, and their interactions were predicted using database of STRING 9.1 \[[@B32-ijms-16-16242]\]. Two possible regulatory networks of interactions among miRNAs and their targets were constructed ([Figure 5](#ijms-16-16242-f005){ref-type="fig"}). A total of 20 miRNAs and 34 targets ([Table 4](#ijms-16-16242-t004){ref-type="table"}) were involved in the two networks presented. Most of these 20 miRNAs have rarely been identified for their functional role in growth or muscle development. However, a number of their target genes have been reported to play a key role in regulation of growth, such as *GHR*, *CISH*, *SOCS3*, *APP*, *TGFBR2*, *AKT1* and *FOXO3*, *etc*. \[[@B33-ijms-16-16242]\]. These miRNAs could participate in the regulation of growth through their target genes. For instance, gga-miR-34c has six targets in the present network, including *SOCS3*, *GCG*, *APP*, *THY1*, *COL11A1* and *MYH7B*; gga-miR-146b-3p was predicted to target *GHR* and *AKT1*; gga-miR-223 was predicted to target *FOXO3* and *ADAM17*; and the predicted target gene of gga-miR-9-5p was *TGFBR2*.
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###### 

Growth related biological processes identified by GO analysis for target genes of 22 highly differentially expressed miRNAs.

  GO Accession   GO Terms                                                                Gene Numbers   Fold Enrichment   *p* Value
  -------------- ----------------------------------------------------------------------- -------------- ----------------- -----------
  GO:0040008     regulation of growth                                                    29             1.5               0.016
  GO:0001558     regulation of cell growth                                               16             1.8               0.019
  GO:0045927     positive regulation of growth                                           11             2                 0.029
  GO:0030307     positive regulation of cell growth                                      5              3.1               0.025
  GO:0017015     regulation of transforming growth factor β receptor signaling pathway   5              2.8               0.034
  GO:0055001     muscle cell development                                                 11             2.4               0.034
  GO:0051146     striated muscle cell differentiation                                    13             1.8               0.040
  GO:0060415     muscle tissue morphogenesis                                             6              2.7               0.049
  GO:0003012     muscle system process                                                   13             1.8               0.049
  GO:0060537     muscle tissue development                                               17             1.6               0.036
  GO:0055002     striated muscle cell development                                        8              2.1               0.035
  GO:0014706     striated muscle tissue development                                      16             1.5               0.027

![Interaction network of highly differentially expressed miRNAs and their potential targets. Candidate miRNA targets were obtained from growth related GO terms; and target--target pair interactions were searched using the STRING database. In the network; blue nodes denoted miRNAs and blue arrows denoted miRNA-target interaction; green nodes denoted targets and green lines denote target--target interaction.](ijms-16-16242-g005){#ijms-16-16242-f005}

2.5. Validation of miR-146b-3p Targeted GHR Gene
------------------------------------------------

DF-1 cells were transfected with miR-146b-3p mimics or inhibitor, and then the expression levels of miR-146b-3p and the *GHR* gene were detected after 48 h. The results show that overexpression of miR-146b-3p downregulated *GHR* mRNA expression ([Figure 6](#ijms-16-16242-f006){ref-type="fig"}A), and that the inhibition of endogenous miR-146b-3p increased *GHR* mRNA expression ([Figure 6](#ijms-16-16242-f006){ref-type="fig"}B). We constructed two dual-luciferase reporters with the wild-type or mutant of *GHR* inserted at the 3′ end of the firefly luciferase gene ([Figure 6](#ijms-16-16242-f006){ref-type="fig"}C). Dual-luciferase reporters assay showed that miR-146b-3p significantly reduced the firefly luciferase activity of the wild-type GHR reporter (*p* \< 0.05) compared with no-insert control ([Figure 6](#ijms-16-16242-f006){ref-type="fig"}C). Furthermore, when miR-146b-3p was co-transfected with the mutant reporter, the firefly luciferase activity was only slightly decreased (*p* \> 0.05) compared with the no-insert control. The expression of miR-146b-3p and *GHR* were detected in our sequencing samples, and the results indicate that their expression reveals a negative relationship ([Figure 7](#ijms-16-16242-f007){ref-type="fig"}). The expression of miR-146b-3p was higher (*p* \< 0.05) in chickens with low body weight than those with high body weight in both WRR and XH chickens ([Figure 7](#ijms-16-16242-f007){ref-type="fig"}B), while the expression of *GHR* was higher in chickens with high body weight than those with low body weight ([Figure 7](#ijms-16-16242-f007){ref-type="fig"}C). These results indicated that the predicted site of *GHR* is a target of miR-146b-3p.

![*GHR* is a target of miR-146b-3p in chickens. (**A**) The mRNA expression of *c-GHR* is significantly reduced after miR-146b-3p transfection in DF-1; (**B**) The mRNA expression of *c-GHR* is significantly increased after miR-146b-3p inhibitor transfection in DF-1; (**C**) DF-1 cells were transfected with miR-146b-3p mimic and co-transfected with no-insert control; *c-GHR* wild-type or mutant luciferase reporters. The predicted binding site and mutated site of miR-146b-3p in *c-GHR* is shown. All of the results are expressed as the mean ± S.E.M. of three replicates. \* *p* \< 0.05; \*\* *p* \< 0.01; ^a,b^ *p* \< 0.05. WT indicates *c-GHR* wild-type luciferase reporter and Mut indicates *c-GHR* mutant luciferase reporter.](ijms-16-16242-g006){#ijms-16-16242-f006}

![The expression of miR-146b-3p and GHR in breast muscle of two-tail samples of WRR and XH. (**A**) The reads of miR-146b-3p in four sequencing samples; (**B**) The expression of miR-146b-3p in two-tail samples of WRR and XH detected by qPCR; (**C**) The expression of *GHR* in two-tail samples of WRR and XH detected by qPCR. All of the results are expressed as the mean ± S.E.M. of three replicates. \* *p* \< 0.05.](ijms-16-16242-g007){#ijms-16-16242-f007}

3. Discussion
=============

Small RNA sequencing can uncover miRNAs expression at an overall level; it has become a useful tool for identifying functional miRNAs. Many miRNAs have been identified as being associated with animal growth performance by high-throughput sequencing \[[@B26-ijms-16-16242],[@B34-ijms-16-16242],[@B35-ijms-16-16242]\]. In this study, we firstly reported the miRNAs expression profiles of chicken breast muscle between fast-growing and slow-growing chicken breeds. The sequence analysis showed that the main size of small RNAs in chicken breast muscle was 21--24, and 22 nt is the predominant size. This result was consistent with the known 19--24 nt range for miRNAs, and previous studies in chicken skeletal muscle and ovary also have similar findings \[[@B36-ijms-16-16242],[@B37-ijms-16-16242]\]. In our sequencing libraries, a total of 921 miRNAs were detected, including 733 known miRNAs and 188 novel miRNAs. The three miRNAs of the gga-miR-133 family (gga-miR-133a, gga-miR-133b and gga-miR-133c) were the most abundant miRNAs in our breast muscle libraries. Previous studies showed that miR-133a was specifically expressed in muscle and regulates the process of skeletal muscle proliferation \[[@B38-ijms-16-16242]\]. Overexpression of miR-133 could inhibit myoblast differentiation, but promotes myoblast proliferation by targeting *SRF* (serum response factor) \[[@B39-ijms-16-16242]\]. The other abundantly expressed miRNAs family in our libraries was gga-let-7, which also was reported to have abundant expression in chicken skeletal muscle \[[@B40-ijms-16-16242]\]. The family of let-7 miRNAs has been shown to play vital roles in mediating cell proliferation and differentiation, in particular, gga-let-7b has demonstrated a role in growth regulation through targeting *GHR* \[[@B26-ijms-16-16242]\]. Of the top 20 abundantly expressed miRNAs identified, some, such as miR-133, miR-10b, miR-26a, miR-30e and gga-miR-30a were also abundantly expressed in chicken somites \[[@B41-ijms-16-16242]\].

miRNAs have an important role in muscle tissues during embryonic development and miR-133, miR-1 and miR-206 are crucial regulatory factors during myogenesis \[[@B19-ijms-16-16242],[@B38-ijms-16-16242],[@B42-ijms-16-16242],[@B43-ijms-16-16242]\]. In the present study, gga-miR-133 was expressed most highly in our samples, which indicated that it might also play a key role in chicken postnatal stages. Furthermore, miR-206 was also abundantly expressed in our samples, while miR-1 was not. These results suggest that some miRNAs might regulate muscle tissues during all development process, whereas some might play a key role only during a special muscle development stage. Differentially expressed miRNAs were confirmed by qPCR analysis. The good correlation between the two methods indicated that deep sequencing results were credible. A total of 22 highly differentially expressed miRNAs (fold change \> 2 or \< 0.5; *p*-value \< 0.05; *q*-value \< 0.01), which also have abundant expression (read counts \> 1000) were found in our comparisons. Among these miRNAs, miR-21 was found to be highly expressed in many species, and associated with cardiac disease and a wide variety of human cancers \[[@B44-ijms-16-16242],[@B45-ijms-16-16242]\]. In this study, miR-21 was upregulated in low-body weight of both WRR and XH chickens. Different expression levels of miR-21 were found in chicken skeletal muscle of different growth periods \[[@B26-ijms-16-16242]\], and in skeletal muscle between broiler and layer \[[@B37-ijms-16-16242]\]. One recent study showed that miR-21 can inhibit cell proliferation \[[@B46-ijms-16-16242]\], suggesting that it might be a negative regulatory factor for chicken growth. These highly differentially expressed miRNAs may play a key role in chicken growth traits, and could be used as candidate genes for further study. However, with the exception of miR-21, most of these miRNAs were little known in terms of growth. It is known that the effects of miRNAs are mainly through regulating the expression of target genes \[[@B13-ijms-16-16242]\]. Therefore, target gene prediction, and annotation of their biological function is useful to predict miRNA function. In this study, we used two different methods to predict the targets for the differently expressed miRNAs, and removed the different targets to reduce false-positive predictions. A total of 3151 consensus targets were obtained for the 22 highly differentially expressed miRNAs. The GO result showed that 192 biological process categories were significantly enriched (*p* \< 0.05) for these targets, including many growth-related biological processes, such as regulation of growth, cell growth, muscle cell differentiation and development, and transforming growth factor beta receptor signaling pathway.

Regulatory networks of interactions among miRNAs and their targets were constructed by using String 9.1. Many target genes in the present interaction networks have been reported to play a key role in regulation of growth. *GHR* and *GH1* are crucial genes of the hypothalamus-pituitary growth axis, which plays a major role in regulating chicken growth \[[@B47-ijms-16-16242],[@B48-ijms-16-16242]\]. Interaction networks predicted that GHR was a target of miR-146b-3p, and this was confirmed by dual-luciferase reporter assay and qPCR in our study. Chicken miR-146b-3p may regulate muscle growth by inhibiting *GHR* expression. In human, miR-146b was reported to promote myogenic differentiation and modulate multiple gene targets in muscle cells, and might be involved in the pathogenesis of asthma and Myotonic Dystrophy Type-2 \[[@B49-ijms-16-16242],[@B50-ijms-16-16242],[@B51-ijms-16-16242]\]. *SOCS3* and *CISH* interacted with *GHR* directly in the network analysis. As a target of miR-34c, *SOCS3* is a suppressor of cytokine signaling which affects cell proliferation, differentiation, apoptosis, and immunoregulation \[[@B52-ijms-16-16242]\]. *SOCS3* could block insulin signaling by targeting insulin receptor substrate 1 (IRS1) and insulin receptor substrate 2 (IRS2) \[[@B53-ijms-16-16242]\]. It also blocks the JAK/STAT pathway, relying on binding to the janus kinase. *CISH* is a target of miR-21, miR-383 and miR-205a. *CISH* is also a cytokine signaling factor, such as *SOCS3*, which was reported to inhibit GHR-JAK2 signaling to *STAT5b* by interacting with the tyrosine kinase *JAK2* or the cytoplasmic tail of *GHR* \[[@B54-ijms-16-16242]\]. In this network, *AKT1*, another target of miR-146b-3p, was predicted to interact with *FOXO3*. The AKT-FOXO3 pathway has been reported to affect the *IGF1* pathway by regulating miR-1 expression \[[@B55-ijms-16-16242]\]. *FOXO3* is an important member of the transcriptional regulatory factor FOXO family; it was found involved in insulin and the *IGF1* signaling pathway, which has an important role in growth \[[@B56-ijms-16-16242]\]. The transcriptional regulatory activity of *FOXO3* can affect muscle growth, and *FOXO3* knockout mice were shown to have a stronger ability to regenerate muscle \[[@B57-ijms-16-16242],[@B58-ijms-16-16242]\]. miR-223 and miR-142-5p were found to potentially target the *FOXO3* gene in our study. miR-223 was reported to associate with cell growth and proliferation, many signal pathways and various tumors \[[@B59-ijms-16-16242],[@B60-ijms-16-16242],[@B61-ijms-16-16242]\]. It can regulate the expression of *IGF1R* in tumor tissue, and thus act as a potential tumor suppressor \[[@B62-ijms-16-16242]\]. miR-223 was also found to regulate the cell proliferation by decreasing the *FOXO1* gene expression in human \[[@B63-ijms-16-16242]\]. Some studies indicate that miR-142-5p could target and regulate cell cycle related genes, and inhibit vascular smooth muscle cell proliferation by down-regulating cell cycle progression \[[@B64-ijms-16-16242],[@B65-ijms-16-16242]\]. The TGF-β signaling pathway is involved in many cellular processes including cell growth and differentiation \[[@B66-ijms-16-16242],[@B67-ijms-16-16242]\], and the TGF-β signaling gene was also involved in the present network. *TGFBR2* was regulated by miR-9-3p and interacted with *TGFB* and *TGFBR1*. All these investigations indicate that the highly differentially expressed miRNAs are closely related to growth of chicken through interaction with their target genes; further studies are needed to reveal their regulatory mechanisms involved in chicken growth.

4. Experimental Section
=======================

4.1. Ethics Statement
---------------------

Animal experiments were handled in compliance with and approved by the Animal Care Committee of South China Agricultural University (Guangzhou, China) with approval number SCAU\#0011, 3 August 2010. All efforts were made to minimize animal subject suffering.

4.2. Sample Preparation
-----------------------

Two chicken breeds, WRR (a breed with a fast growth rate) and XH (Chinese native breed with a slow growth rate), were used for Solexa sequencing. In this study, the animals were the same as those used in our previous research on MeDIP-Seq \[[@B68-ijms-16-16242]\]. Three female birds from each of the two-tail groups of WRR and XH at 7 weeks were selected, and then four groups including WRRh, WRRl, XHh and XHl were generated. The averages of body weight values were 1064.0 ± 11.1, 695.0 ± 24.4, 305.8 ± 23.3, and 207.6 ± 11.1 g for WRRh, WRRl, XHh, and XHl group, respectively. All chickens were euthanized by decapitation for tissues collection. Breast muscle tissues of the 12 individuals were rapidly dissected and immediately placed in liquid nitrogen then stored at −80 °C.

4.3. Small RNA Library Construction and Solexa Sequencing
---------------------------------------------------------

Total RNA was extracted from each breast muscle using Trizol (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The quality and concentration of all twelve RNA samples were determined by 1.5% agarose gel electrophoresis and absorbance at A260/280 ratio, and then divided to four mixed RNA pools for WRRh, WRRl, XHh, and XHl. Subsequently, 20 µg of total RNA were purified by denaturing 15% PAGE to enrich for 16--32 nt small RNAs, and then ligated with proprietary adapters. The ligated products were purified and reverse transcribed to cDNA to produce libraries. Finally, the libraries were deep sequenced using Genome Analyzer IIx (Illumina, San Diego, CA, USA) at Shanghai Majorbio Bio-pharm Biotechnology Co., Ltd. (Shanghai, China).

4.4. Sequence Analysis
----------------------

The original image figure from sequencing was converted into sequence data (raw reads) by the base-calling step. For all generated raw reads, adaptor sequences, low quality reads (Sanger bases quality \< 20), and contaminant reads were removed with the Fastx-Toolkit software \[[@B69-ijms-16-16242]\]. The final data were named as clean reads. Firstly, clean reads from 18--32 nt were counted and the identical sequences eliminated. Subsequently, the assembled unique sequences were identified for the type and number of small RNA (rRNAs, tRNA, sn/snoRNAs, miRNAs, other noncoding RNAs) using Rfam databases 10.1 (<http://rfam.sanger.ac.uk/>). Meanwhile, the sequences were mapped to chicken genome to annotate the location in the chromosomes using Bowtie \[[@B70-ijms-16-16242]\]. Finally, the remaining sequences were analyzed through BLASTing the miRbase 21.0 (<http://www.mirbase.org/>), to identify the known miRNAs in chicken. Furthermore, the novel miRNAs were predicted using miRDeep2 (<https://www.mdc-berlin.de/8551903/en/>) \[[@B28-ijms-16-16242]\] from unannotated sRNAs.

4.5. Analysis of Differently Expressed miRNAs
---------------------------------------------

DEGseq package (<http://www.bioconductor.org/packages/release/bioc/html/DEGseq.html>) was used to analyze differentially expressed miRNAs in this study \[[@B71-ijms-16-16242]\]. The miRNAs expression in each library (WRRh, WRRl, XHh, and XHl) was normalized to obtain the expression of transcripts per million using total clean reads count. If the normalized reads of a given miRNAs is less than 20 in all libraries, it was removed in future differential expression analyses. Two contrasts of WRRh *vs.* WRRl and XHh *vs.* XHl were analyzed, and the fold-changes and *p*-value were calculated from the normalized reads. The differentially expressed miRNAs are identified only if \|log2Ratio\| \> 0.585 (fold-change value \> 1.5) and *p*-value \< 0.05.

4.6. Target Gene Prediction, Pathway and Network Analysis
---------------------------------------------------------

Both known and novel miRNAs were used to predict the miRNAs potential targets by RNAhybrid (<http://bibiserv.techfak.uni-bielefeld.de/rnahybrid/>) \[[@B31-ijms-16-16242]\] and miranda (<http://www.microrna.org/microrna/home.do>) \[[@B30-ijms-16-16242]\]. Only the target genes predicted by both of two methods were considered as reliable targets for further analysis. All target genes of differentially expressed miRNAs were subjected to Gene Ontology (GO) and KEGG pathway enrichment analysis by using DAVID 6.7 Functional Annotation Tool (<http://david.abcc.ncifcrf.gov/>). The results were filtered based on a Fisher Exact statistic methodology similar to that previously described \[[@B72-ijms-16-16242]\]. Gene interaction analysis was performance by String 9.1 (<http://www.string-db.org/>) \[[@B32-ijms-16-16242]\], and a medium Pearson Correlation Coefficient (PCC) value of 0.4 was used as a cutoff \[[@B73-ijms-16-16242]\].

4.7. RNA Oligonucleotides and Transfection
------------------------------------------

The miR-146b-3p mimics, inhibitors of miR-146b-3p, mimic NC and inhibitor NC were purchased from GenePharma (GenePharma, Suzhou, China). The DF-1 chicken fibroblast cell line was cultured at 37 °C in high-glucose Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY, USA) supplemented with 10% (*v*/*v*) fetal bovine serum (Hyclone, Logan, UT, USA), and 100 μg/mL penicillin/ streptomycin (Invitrogen). Transfection was performed with the Lipofectamine 3000 reagent (Invitrogen) combined with 50 nM of miRNA mimics, 120 nM of inhibitors, and the procedure was performed according to the manufacturer's instructions.

4.8. cDNA Synthesis and Quantitative Real Time PCR (qPCR)
---------------------------------------------------------

Total RNA of each sample and cultured cells were polyadenylated and reverse transcribed to cDNA using miScript Reverse Transcription kit (Qiagen, Valencia, CA, USA). The miScript SYBR Green PCR kit (Qiagen, Valencia, CA, USA) was used in qPCR to determine the expression of miRNA. U6 and GAPDH genes were chosen as reference genes for miRNAs and gene expression respectively. The primers of miRNAs and related genes were designed by Primer 5.0 ([Table S6 in supplementary information](#app1-ijms-16-16242){ref-type="app"}), and universal primer of miRNAs was offered by miScript SYBR Green PCR kit. qPCR program was performed in a BIO-RAD CFX96 system (Bio-Rad Laboratories Inc., Hercules, CA, USA) as follows: 95 °C for 2 min; 40 cycles of 95 °C for 10 s, 56 °C for 30 s; 72 °C for 30 s and 72 °C for 1 min. The relative expression level of miRNA was calculated using the comparative 2^−∆*C*t^ (∆*C*t = *C*t~target\ gene~ − *C*t~U6~). Fold change values were calculated using the comparative 2^−∆∆*C*t^, in which ∆∆*C*t = ∆*C*t (target gene) − ∆*C*t (reference gene). All reactions were run in triplicate and presented as means ± S.E.M. The Student's *t*-test was used to compare expression levels among different groups.

4.9. pmirGLO Dual-Luciferase miRNA Target Expression Vector Construction and Dual-Luciferase Reporter Assay
-----------------------------------------------------------------------------------------------------------

The sequences of *c-GHR* were amplified from the chicken genome and cloned into the pmirGLO dual-luciferase reporter vector (Promega, Madison, WI, USA) using the *Pme* I and *xho* I restriction sites. The mutant *c-GHR* plasmids were generated through changing the miR-146b-3p binding site from ATCCAT to AAGACT ([Figure 7](#ijms-16-16242-f007){ref-type="fig"}C), and mutagenesis was performed by PCR amplification and DpnI digestion to remove the parental DNA. DF-1 cells were co-transfected with 100 ng of the wild-type, mutant 3′-UTR or no-insert control dual-luciferase reporter and 50 nM of the miR-146b-3p mimic using Lipofectamine 3000 reagent in 96-well plates. After transfection for 48 h, the activities of firefly and Renilla luciferase were analysed using a dual-luciferase reporter assay system (Promega) following the manufacturer's instructions. The luminescent signal was quantified using a Fluorescence/Multi-Detection Microplate Reader (Synergy 2, Biotek, Winooski, VT, USA) and analyzed with Gene5 software (Biotek, Bad Friedichshall, Germany).

5. Conclusions
==============

In the present study, we have characterized the miRNAs expression profile of breast muscle between fast- and slow-growing chickens for the first time. There were 80 and 110 shared differentially expressed miRNAs identified in within-breed comparisons (WRRh *vs.* WRRl, and XHh *vs.* XHl) and across-breed contrasts (WRRh *vs.* XHh, and WRRl *vs.* XHl), respectively. Moreover, there were 26 miRNAs significantly differentially expressed among all four comparisons. We focused on 22 highly differentially expressed miRNAs that also were abundantly expressed. To investigate the functional roles of these miRNAs, GO analysis and the interaction network of these miRNAs and their putative targets were constructed. These integrated analyses may predict several candidates for future studies concerning miRNAs-target function on regulation of chicken growth.

This research was funded by the Program for New Century Excellent Talents in University (NCET-13-0803), the Natural Scientific Foundation of China (31172200; 31472090), and the Foundation for High-level Talents in Higher Education of Guangdong, China. The funders played no role in the study design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.

###### 

Click here for additional data file.

Supplementary materials can be found at <http://www.mdpi.com/1422-0067/16/07/16242/s1>.

Hongjia Ouyang carried out the data analysis and drafted the manuscript. Xiaomei He and Guihuan Li performed the validation experiments. Haiping Xu and Xingzheng Jia helped to analyse and interpret data. Qinghua Nie conceived and designed the study and helped to draft the manuscript. Xiquan Zhang helped with the conception and design of the study. All authors read and approved the final manuscript.

The authors declare no conflict of interest.
